Definition of valid proteomic biomarkers: a bayesian solution

Article English OPEN
Harris, K. ; Girolami, M. ; Mischak, H. (2009)

Clinical proteomics is suffering from high hopes generated by reports on apparent biomarkers, most of which could not be later substantiated via validation. This has brought into focus the need for improved methods of finding a panel of clearly defined biomarkers. To examine this problem, urinary proteome data was collected from healthy adult males and females, and analysed to find biomarkers that differentiated between genders. We believe that models that incorporate sparsity in terms of variables are desirable for biomarker selection, as proteomics data typically contains a huge number of variables (peptides) and few samples making the selection process potentially unstable. This suggests the application of a two-level hierarchical Bayesian probit regression model for variable selection which assumes a prior that favours sparseness. The classification performance of this method is shown to improve that of the Probabilistic K-Nearest Neighbour model.
  • References (12)
    12 references, page 1 of 2

    1. Mischak, H., Apweiler, R., Banks, R.E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J.H.H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B.A., Kolch, W., Massy, Z.A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O.J., Theodorescu, D., Thongboonkerd, V., Weissinger, E.M., Van Eyk, J.E., Yamamoto, T.: Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics - Clinical Applications 1(2) (February 2007) 148-156

    2. Decramer, S., de Peredo, A.G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.L., Schanstra, J.P.: Urine in clinical proteomics. Molecular and Cellular Proteomics 7(10) (October 2008) 1850-1862

    3. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., Liotta, L.A.: Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 359(9306) (February 2002) 572-577

    4. Check, E.: Proteomics and cancer - running before we can walk? Nature 429(6991) (June 2004) 496-497

    5. Mischak, H., Coon, J.J., Novak, J., Weissinger, E.M., Schanstra, J.P., Dominiczak, A.F.: Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developments. Mass Spectrometry Reviews In press (October 2008)

    6. Coon, J.J., Zu¨rbig, P., Dakna, M., Dominiczak, A.F., Decramer, S., Fliser, D., Frommberger, M., Golovko, I., Good, D.M., Herget-Rosenthal, S., Jankowski, J., Julian, B.A., Kellmann, M., Kolch, W., Massy, Z., Novak, J., Rossing, K., Schanstra, J.P., Schiffer, E., Theodorescu, D., Vanholder, R., Weissinger, E.M., Mischak, H., Schmitt-Kopplin, P.: CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics - Clinical Applications 2(7-8) (July 2008) 964-973

    7. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., Metzger, J.: Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. Journal of Proteome Research 8(1) (2009) 268-281

    8. Manocha, S., Girolami, M.: An empirical analysis of the probabilistic k-nearest neighbour classifier. Pattern Recognition Letters 28(13) (2007) 1818-1824

    9. Holmes, C.C., Adams, N.M.: A probabilistic nearest neighbour method for statistical pattern recognition. J. R. Statist. Soc. B 64(2) (2002) 295-306

    10. Everson, R.M., Fieldsend, J.E.: A variable metric probabilistic k-nearestneighbours classifier. In: Intelligent Data Engineering and Automated Learning - IDEAL. (2004) 654-659

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark